P-197: Successful reversal of post-renal transplant (PRT) erythrocytosis (ERY) with angiotensin-converting enzyme inhibitor (ACEi).

MLA

Pabico, R. C., et al. “P-197: Successful Reversal of Post-Renal Transplant (PRT) Erythrocytosis (ERY) with Angiotensin-Converting Enzyme Inhibitor (ACEi).” American Journal of Hypertension, vol. 14, Apr. 2001, p. 95A. EBSCOhost, https://doi.org/10.1016/S0895-7061(01)01387-5.

APA

Pabico, R. C., McKenna, B. A., Yoo, K., Byer, B., Yarger, J., Kremer, M., Monaghan, J., Stewart, K., & O’Mara, R. (2001). P-197: Successful reversal of post-renal transplant (PRT) erythrocytosis (ERY) with angiotensin-converting enzyme inhibitor (ACEi). American Journal of Hypertension, 14, 95A. https://doi.org/10.1016/S0895-7061(01)01387-5

Chicago

Pabico, R. C., B. A. McKenna, K. Yoo, B. Byer, J. Yarger, M. Kremer, J. Monaghan, K. Stewart, and R. O’Mara. 2001. “P-197: Successful Reversal of Post-Renal Transplant (PRT) Erythrocytosis (ERY) with Angiotensin-Converting Enzyme Inhibitor (ACEi).” American Journal of Hypertension 14 (April): 95A. doi:10.1016/S0895-7061(01)01387-5.